BHVN
insider transactionsBiohaven Ltd. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Cluster buy signal: Multiple insiders at the same company buying around the same time — often a stronger signal than a single buy. 4 different insiders made open-market purchases in the last 365 days, totalling $33.1M.
Net shares · 365d
+4.4M
4.4M buy · 0 sell
Net value · 365d
$33.1M
$33.1M in · $0 out
Sentiment · 365d
Net buying
100% buying · 0% selling
Open-market trades · 365d
5
4.4M buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
68.7K sh
Own New
-
Grant·A
Director
$0
68.7K sh
Own New
-
Grant·A
Director
$0
68.7K sh
Own New
-
Grant·A
Director
$0
68.7K sh
Own New
-
Grant·A
Director
$0
68.7K sh
Own New
-
Grant·A
Director
$0
68.7K sh
Own New
-
Grant·A
Director
$0
68.7K sh
Own New
-
Other·G
Director
$0
17.3K sh
Own -50%
-
Other·G
Director
$0
17.3K sh
Own -77%
-
Grant·A
SVP, Clinical Operations
$0
175.0K sh
Own New
-
Grant·A
Coric Vlad KEY
Chief Executive Officer
$0
550.0K sh
Own New
-
Grant·A
Chief Scientific Officer
$0
175.0K sh
Own New
-
Grant·A
VP, Chief Accounting Officer
$0
50.0K sh
Own New
-
Grant·A
Buten Matthew KEY
Chief Financial Officer
$0
175.0K sh
Own New
-
Exercise·M
VP, Chief Accounting Officer
$0
2.5K sh
Own +100%
-
Other·F
VP, Chief Accounting Officer
$11.1K
1.1K sh · $9.93
Own -2%
-
Exercise·M
VP, Chief Accounting Officer
$0
2.5K sh
Own +4%
-
Exercise·M
Buten Matthew KEY
Chief Financial Officer
$0
4.2K sh
Own +100%
-
Exercise·M
Buten Matthew KEY
Chief Financial Officer
$0
4.2K sh
Own +2%
-
Other·F
Buten Matthew KEY
Chief Financial Officer
$25.8K
2.6K sh · $9.93
Own -1%
-
Exercise·M
SVP, Clinical Operations
$0
3.8K sh
Own +100%
-
Exercise·M
SVP, Clinical Operations
$0
3.8K sh
Own +4%
-
Other·F
SVP, Clinical Operations
$19.4K
2.0K sh · $9.93
Own -2%
-
Exercise·M
Chief Scientific Officer
$0
4.8K sh
Own +100%
-
Exercise·M
Chief Scientific Officer
$0
4.8K sh
Own +89%
-
Other·F
Chief Scientific Officer
$23.6K
2.4K sh · $9.93
Own -24%
-
Exercise·M
Coric Vlad KEY
Chief Executive Officer
$0
14.2K sh
Own +100%
-
Exercise·M
Coric Vlad KEY
Chief Executive Officer
$0
14.2K sh
Own +1%
-
Other·F
Coric Vlad KEY
Chief Executive Officer
$73.8K
7.4K sh · $9.93
Own -0%
-
Buy·P
VP, Chief Accounting Officer
$144.8K
17.0K sh · $8.52
Own +567%
-
Buy·P
Coric Vlad KEY
Chief Executive Officer
$2.5M
333.3K sh · $7.50
Own +39%
-
Buy·P
Coric Vlad KEY
Chief Executive Officer
$2.5M
333.3K sh · $7.50
Own +82%
-
Buy·P
Director
$25.0M
3.3M sh · $7.50
Own +144%
-
Buy·P
Director
$3.0M
400.0K sh · $7.50
Own +25%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Apr 28, 2026 | Mehta Kishan | Grant A | 68.7K | $0 |
| Apr 28, 2026 | Heffernan Michael Thomas | Grant A | 68.7K | $0 |
| Apr 28, 2026 | HUGIN ROBERT J | Grant A | 68.7K | $0 |
| Apr 28, 2026 | GREGORY JULIA P | Grant A | 68.7K | $0 |
| Apr 28, 2026 | CHILDS JOHN W | Grant A | 68.7K | $0 |
| Apr 28, 2026 | Bailey Gregory | Grant A | 68.7K | $0 |
| Apr 28, 2026 | Antonijevic Irina | Grant A | 68.7K | $0 |
| Mar 17, 2026 | Mehta Kishan | Other G | 17.3K | $0 |
| Mar 17, 2026 | Mehta Kishan | Other G | 17.3K | $0 |
| Feb 27, 2026 | Gentile Kimberly | Grant A | 175.0K | $0 |
| Feb 27, 2026 | Coric Vlad KEY | Grant A | 550.0K | $0 |
| Feb 27, 2026 | Car Bruce | Grant A | 175.0K | $0 |
| Feb 27, 2026 | Clark George C. | Grant A | 50.0K | $0 |
| Feb 27, 2026 | Buten Matthew KEY | Grant A | 175.0K | $0 |
| Jan 5, 2026 | Clark George C. | Exercise M | 2.5K | $0 |
| Jan 5, 2026 | Clark George C. | Other F | 1.1K | $11.1K |
| Jan 5, 2026 | Clark George C. | Exercise M | 2.5K | $0 |
| Jan 5, 2026 | Buten Matthew KEY | Exercise M | 4.2K | $0 |
| Jan 5, 2026 | Buten Matthew KEY | Exercise M | 4.2K | $0 |
| Jan 5, 2026 | Buten Matthew KEY | Other F | 2.6K | $25.8K |
| Jan 5, 2026 | Gentile Kimberly | Exercise M | 3.8K | $0 |
| Jan 5, 2026 | Gentile Kimberly | Exercise M | 3.8K | $0 |
| Jan 5, 2026 | Gentile Kimberly | Other F | 2.0K | $19.4K |
| Jan 5, 2026 | Car Bruce | Exercise M | 4.8K | $0 |
| Jan 5, 2026 | Car Bruce | Exercise M | 4.8K | $0 |
| Jan 5, 2026 | Car Bruce | Other F | 2.4K | $23.6K |
| Jan 5, 2026 | Coric Vlad KEY | Exercise M | 14.2K | $0 |
| Jan 5, 2026 | Coric Vlad KEY | Exercise M | 14.2K | $0 |
| Jan 5, 2026 | Coric Vlad KEY | Other F | 7.4K | $73.8K |
| Nov 17, 2025 | Clark George C. | Buy P | 17.0K | $144.8K |
| Nov 13, 2025 | Coric Vlad KEY | Buy P | 333.3K | $2.5M |
| Nov 13, 2025 | Coric Vlad KEY | Buy P | 333.3K | $2.5M |
| Nov 13, 2025 | CHILDS JOHN W | Buy P | 3.3M | $25.0M |
| Nov 13, 2025 | Bailey Gregory | Buy P | 400.0K | $3.0M |
About BHVN insider trading
This page tracks insider transactions for Biohaven Ltd. (BHVN) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.